Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

US Patent 10494442 · Granted Dec 3, 2019

Estimated economic value: $124,542,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhib2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
ANGPTL8 assay and uses thereof2024
Non-human animals comprising a humanized ASGR1 locus2023
Anti-MSR1 antibodies and methods of use thereof2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody2021
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody2021
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody2021
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody2021